Solution

At Present, The Company Has Established Extensive, In-depth And Long-term Cooperative Relationships With Many Hospitals, And Researches On Multiple Cancers Such As Lung Cancer, Colorectal Cancer And Gynecological Tumors. The Research Direction Covers The Screening Of Early Tumor Markers And The Prognosis. Evaluation, Tumor Heterogeneity Molecular Classification And Other Fields, And

Achieved Fruitful Results.

01
Comprehensive NGS tumor profiling panel for all solid tumors.
  • The relationship between cancer treatment and genetic testing.
  • Advantages and characteristics.
  • Case.
02
NGS tumor profiling panel for non-small cell lung cancer.
  • The relationship between cancer treatment and genetic testing.
  • Medical reference.
  • Advantages and characteristics.
  • Case.
03
NGS tumor profiling panel for colorectal cancer.
  • The relationship between cancer treatment and genetic testing.
  • Medical reference.
  • Advantages and characteristics.
  • Case.
04
MammaPrint product.
  • Product description.
  • Authoritative guide recommended.
  • Authorized qualification.
05
PD-L1/PD-1,and MMR for solid tumors.
  • Strict quality control.
  • Inspection request.
  • PD-L 1/ PD-1 and mismatched four (MMR) protein assay reports.